Pulmatrix PULM
NASDAQ PULM
$1.59 +0.05 (+3.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pulmatrix (PULM) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Pulmatrix (PULM) posted Return on Capital Employed [ROCE] of -129.23% for Q2 2026, down 7.09 percentage points from -122.13% a year earlier but up 5.98 percentage points from the prior quarter.

Analysis

Pulmatrix (PULM) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Pulmatrix's Return on Capital Employed [ROCE] came in at -77.01%, down 30.57 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -42.91 percentage points (FY2020 to FY2025).
  • In prior years, Pulmatrix's Return on Capital Employed [ROCE] was -46.44% in FY2024 (-2.50 pp), -43.94% in FY2023 (-1.71 pp), -42.23% in FY2022 (+3.59 pp) and -45.82% in FY2021 (-11.71 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -152.67% in Q1 2025 to a high of -32.41% in Q1 2024 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in 1 of the last eight quarters, with an average year-over-year change of -39.06 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 22.57 percentage points; the weakest was Q1 2025, with a drop of 120.26 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -135.21% (Q1 2026), -122.16% (Q4 2025) and -116.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Pulmatrix 5.81 Mn 5.81 Mn - -129.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -129.23%
Mar 31, 2026 -135.21%
Dec 31, 2025 -122.16%
Sep 30, 2025 -116.83%
Jun 30, 2025 -122.13%
Mar 31, 2025 -152.67%
Dec 31, 2024 -99.65%
Sep 30, 2024 -76.87%
Jun 30, 2024 -54.90%
Mar 31, 2024 -32.41%
Dec 31, 2023 -46.86%
Sep 30, 2023 -56.79%
Jun 30, 2023 -59.75%
Mar 31, 2023 -54.98%
Dec 31, 2022 -48.98%
Sep 30, 2022 -44.87%
Jun 30, 2022 -47.04%
Mar 31, 2022 -41.12%
Dec 31, 2021 -38.17%
Sep 30, 2021 -33.90%
API Access

Pulmatrix Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PULM&period=max&api_key=YOUR_API_KEY